Evaluation of the sentinel lymph node algorithm with blue dye labeling for early-stage endometrial cancer in a multicentric setting

International Journal of Gynecological Cancer

Volumn 23, Issue 7, 2013, Pages 1237-1243

  Vidal, Fabien ^a,d   Leguevaque, Pierre ^a   Motton, Stephanie ^a   Delotte, Jerome ^b   Ferron, Gwenael ^c   Querleu, Denis ^c   Rafii, Arash ^d  

^a CHU RANGUEIL   (France)

^b UNIVERSITÉ CÔTE D'AZUR   (France)

^c INSTITUT CLAUDIUS REGAUD   (France)

^d WEILL CORNELL MEDICAL COLLEGE   (Qatar)

Author keywords

Endometrial cancer; Lymphadenectomy; Sentinel node; SLN algorithm

Indexed keywords

BLEU PATENTE V; DISULFINE BLUE; TAMOXIFEN; UNCLASSIFIED DRUG;

ALGORITHM; ARTICLE; BODY MASS; CANCER DIAGNOSIS; CANCER STAGING; CARCINOSARCOMA; CLEAR CELL CARCINOMA; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; EARLY CANCER; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; FALSE NEGATIVE RESULT; FEMALE; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HYPERTENSION; LOW RISK POPULATION; LYMPH NODE DISSECTION; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS LYMPH NODE; PELVIS LYMPHADENECTOMY; PILOT STUDY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELIABILITY; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE; VAGINA BLEEDING;

ADENOCARCINOMA, CLEAR CELL; ADENOCARCINOMA, PAPILLARY; ALGORITHMS; COLORING AGENTS; CYSTADENOCARCINOMA, SEROUS; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; ROSANILINE DYES; SENTINEL LYMPH NODE BIOPSY;

EID: 84884514071     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e31829b1b98     Document Type: Article

References (37)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10-29.
2. Lurain JR, Rice BL, Rademaker AW, et al. Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium. Obstet Gynecol. 1991;78:63-69.
3. Boente MP, Yordan EL Jr, McIntosh DG, et al. Prognostic factors and long-term survival in endometrial adenocarcinoma with cervical involvement. Gynecol Oncol. 1993;51:316-322.
4. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105: 103-104.
5. Kitchener H, Swart AM, Qian Q, et al. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): A randomised study. Lancet. 2009;373:125-136.
6. Benedetti Panici P, Basile S, Maneschi F, et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst. 2008;100:1707-1716.
7. May K, Bryant A, Dickinson HO, et al.. Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst Rev. 2010;CD007585.
8. Mourits MJ, Bijen CB, de Bock GH. Lymphadenectomy in endometrial cancer. Lancet. 2009;373:1169; author reply 1170Y1171.
9. Amant F, Neven P, Vergote I. Lymphadenectomy in endometrial cancer. Lancet. 2009;373:1169-1170; author reply 1170Y1171.
10. Creasman WT, Mutch DE, Herzog TJ. ASTEC lymphadenectomy and radiation therapy studies: Are conclusions valid? Gynecol Oncol. 2010;116:293-294.
11. Chuang L, Burke TW, Tornos C, et al. Staging laparotomy for endometrial carcinoma: Assessment of retroperitoneal lymph nodes. Gynecol Oncol. 1995;58:189-193.
12. Cragun JM, Havrilesky LJ, Calingaert B, et al. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol. 2005;23:3668-3675.
13. Mangioni C, De Palo G, Marubini E, et al. Surgical pathologic staging in apparent stage I endometrial carcinoma. Int J Gynecol Cancer. 1993;3:373-384.
14. Mariani A, Dowdy SC, Cliby WA, et al. Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients. Gynecol Oncol. 2006;101: 200-208.
15. Seamon LG, Fowler JM, Cohn DE. Lymphadenectomy for endometrial cancer: The controversy. Gynecol Oncol. 2010;117:6-8.
16. Baekelandt MM, Castiglione M. Endometrial carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2009;20:29-31.
17. Querleu D, Planchamp F, Narducci F, et al.. Clinical practice guidelines for the management of patients with endometrial cancer in France: recommendations of the Institut National du Cancer and the Societe Francaise d'Oncologie Gynecologique. Int J Gynecol Cancer. 2011;21:945-950.
18. Ballester M, Dubernard G, Lecuru F, et al. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: A prospective multicentre study (SENTI-ENDO). Lancet Oncol. 2011;12:469-476.
19. How J, Lau S, Press J, et al. Accuracy of sentinel lymph node detection following intra-operative cervical injection for endometrial cancer: A prospective study. Gynecol Oncol. 2012; 127:332-337.
20. Delpech Y, Cortez A, Coutant C, et al. The sentinel node concept in endometrial cancer: histopathologic validation by serial section and immunohistochemistry. Ann Oncol. 2007;18:1799-1803.
21. Ballester M, Naoura I, Chereau E, et al. Sentinel node biopsy upstages patients with presumed low- And intermediate-risk endometrial cancer: results of a multicenter study. Ann Surg Oncol. 2013;20:407-412.
22. Burke TW, Levenback C, Tornos C, et al. Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: results of a pilot study. Gynecol Oncol. 1996;62:169-173.
23. Altgassen C, Pagenstecher J, Hornung D, et al. A new approach to label sentinel nodes in endometrial cancer. Gynecol Oncol. 2007;105:457-461.
24. Mais V, Peiretti M, Gargiulo T, et al. Intraoperative sentinel lymph node detection by vital dye through laparoscopy or laparotomy in early endometrial cancer. J Surg Oncol. 2010;101:408-412.
25. Barlin JN, Khoury-Collado F, Kim CH, et al. The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes. Gynecol Oncol. 2012;125:531-535.
26. Querleu D, Morrow CP. Classification of radical hysterectomy. Gynecol Oncol. 2009;115:314-315; author reply 315Y316.
27. Negrier S, Saiag P, Guillot B, et al. [Clinical practice guideline: 2005 update of recommendations for the management of patients with cutaneous melanoma without distant metastases (summary report)]. Bull Cancer. 2006;93:371-384.
28. Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23:7703-7720.
29. Hampl M, Hantschmann P, Michels W, et al. Validation of the accuracy of the sentinel lymph node procedure in patients with vulvar cancer: results of a multicenter study in Germany. Gynecol Oncol. 2008;111:282-288.
30. Ballester M, Dubernard G, Rouzier R, et al. Use of the sentinel node procedure to stage endometrial cancer. Ann Surg Oncol. 2008;15:1523-1529.
31. Perrone AM, Casadio P, Formelli G, et al. Cervical and hysteroscopic injection for identification of sentinel lymph node in endometrial cancer. Gynecol Oncol. 2008;111:62-67.
32. Bats AS, Clement D, Larousserie F, et al. Does sentinel node biopsy improve the management of endometrial cancer? Data from 43 patients. J Surg Oncol. 2008;97:141-145.
33. Abu-Rustum NR, Gomez JD, Alektiar KM, et al. The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes. Gynecol Oncol. 2009;115:236-238.
34. Delaloye JF, Pampallona S, Chardonnens E, et al. Intraoperative lymphatic mapping and sentinel node biopsy using hysteroscopy in patients with endometrial cancer. Gynecol Oncol. 2007;106:89-93.
35. Torne A, Pahisa J, Vidal-Sicart S, et al. Transvaginal ultrasound-guided myometrial injection of radiotracer (TUMIR): A new method for sentinel lymph node detection in endometrial cancer. Gynecol Oncol. 2013;128:88-94.
36. Khoury-Collado F, Glaser GE, Zivanovic O, et al. Improving sentinel lymph node detection rates in endometrial cancer: how many cases are needed? Gynecol Oncol. 2009;115: 453-455.
37. Holub Z, Jabor A, Lukac J, et al. Laparoscopic detection of sentinel lymph nodes using blue dye in women with cervical and endometrial cancer. Med Sci Monit. 2004;10: CR587-CR591.